China Resources Jiangzhong Pharmaceutical Co.,Ltd (SHA:600750)
China · Delayed Price · Currency is CNY 23.99
-0.93 (-3.73%)
Apr 28, 2026, 3:00 PM CST
SHA:600750 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 909.82 | 906.69 | 788.19 | 718.67 | 598.24 | 505.69 |
Depreciation & Amortization | 148.08 | 148.08 | 136.81 | 126 | 122 | 115.44 |
Other Amortization | 4.24 | 4.24 | 0.94 | 0.86 | 0.45 | 0.3 |
Loss (Gain) From Sale of Assets | -0.61 | -0.61 | -1.84 | -1.22 | 0.13 | -0.9 |
Asset Writedown & Restructuring Costs | 0.68 | 0.68 | 1.05 | 2.04 | - | - |
Loss (Gain) From Sale of Investments | -0.59 | -0.59 | 9.6 | 40.05 | -61.47 | -51.25 |
Provision & Write-off of Bad Debts | -0.48 | -0.48 | 8.67 | -0.34 | 1.34 | -0.31 |
Other Operating Activities | -146.23 | 1.72 | -7.96 | 15.87 | 34.65 | 16.69 |
Change in Accounts Receivable | 256.19 | 256.19 | -326.87 | 257.89 | 9.75 | 159.5 |
Change in Inventory | 9.77 | 9.77 | 10.82 | -50 | -3.3 | -23.63 |
Change in Accounts Payable | -372.51 | -372.51 | 175.97 | -65.85 | 309.96 | 200.5 |
Change in Other Net Operating Assets | 15.24 | 15.24 | 3.63 | 8.94 | 10.66 | 1.19 |
Operating Cash Flow | 826.05 | 970.87 | 786.25 | 1,039 | 1,022 | 917.04 |
Operating Cash Flow Growth | -6.65% | 23.48% | -24.36% | 1.73% | 11.42% | 21.87% |
Capital Expenditures | -283.96 | -280.57 | -290.77 | -211.15 | -345.73 | -188.49 |
Sale of Property, Plant & Equipment | 0.09 | 0.1 | 13.89 | 0.25 | 0.05 | 1.24 |
Cash Acquisitions | -48.85 | -48.85 | - | - | - | 197.89 |
Investment in Securities | 18.91 | -144.65 | 234.93 | 39.68 | 370.87 | -1,308 |
Other Investing Activities | 96.1 | 47.65 | 122.91 | 56.65 | 43.48 | 60.98 |
Investing Cash Flow | -217.71 | -426.33 | 80.97 | -114.58 | 68.67 | -1,237 |
Short-Term Debt Issued | - | 227.64 | - | - | 30 | - |
Total Debt Issued | 227.64 | 227.64 | - | - | 30 | - |
Short-Term Debt Repaid | - | - | - | - | -30 | - |
Long-Term Debt Repaid | - | -1.37 | -1.55 | -1.95 | -2.17 | -0.8 |
Total Debt Repaid | -1.37 | -1.37 | -1.55 | -1.95 | -32.17 | -0.8 |
Net Debt Issued (Repaid) | 226.27 | 226.27 | -1.55 | -1.95 | -2.17 | -0.8 |
Issuance of Common Stock | 93 | 83.95 | - | - | 8.89 | 37.96 |
Repurchase of Common Stock | -0.57 | -0.57 | -1.31 | -1.12 | -2.32 | -73.27 |
Common Dividends Paid | -777.95 | -777.95 | -768.46 | -816.52 | -733.1 | -313.37 |
Other Financing Activities | -19.73 | -19.11 | -86.12 | -13.48 | - | - |
Financing Cash Flow | -478.99 | -487.41 | -857.44 | -833.07 | -728.7 | -349.48 |
Net Cash Flow | 129.35 | 57.13 | 9.78 | 91.82 | 361.72 | -669.02 |
Free Cash Flow | 542.09 | 690.29 | 495.49 | 828.31 | 676.02 | 728.55 |
Free Cash Flow Growth | -10.07% | 39.32% | -40.18% | 22.53% | -7.21% | 27.82% |
Free Cash Flow Margin | 13.31% | 16.36% | 11.17% | 18.19% | 17.40% | 25.35% |
Free Cash Flow Per Share | 0.86 | 1.09 | 0.79 | 1.15 | 1.07 | 1.15 |
Cash Income Tax Paid | 577.86 | 605.96 | 532.47 | 485.59 | 421.79 | 392.17 |
Levered Free Cash Flow | -277.62 | 742.34 | 253.67 | 541.68 | 517.63 | 862.86 |
Unlevered Free Cash Flow | -276.49 | 743.47 | 254.74 | 546.04 | 520.37 | 865.02 |
Change in Working Capital | -88.85 | -88.85 | -149.22 | 137.54 | 326.4 | 331.38 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.